OncoCyte: Already A Commercial Stage Company With Enormous Revenue Potential [Seeking Alpha]
Biocept, Inc. (BIOC)
Last biocept, inc. earnings: 3/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.biocept.com/investor-relations
Company Research
Source: Seeking Alpha
OncoCyteOCXThis 2020 is the year of the definitive transformation of the company, since in the last first quarter it became for the first time in its history, a company in the commercial stage. This was due to the fact that both the DetermaRx test (early detection of lung cancer) and DetermaIO (test that determines whether cancer immunotherapy is effective for patients) are already ready and available for sale.On the other hand, thelatest advances-Clinical validation of DetermaDX that will end soon (end of June)-Request for medical coverage from CMS for DetermaDX test (after its clinical validation)-Commercial availability of DetermaIO platform for research use only in the field of oncological immunology.-Signing of agreements with various health clinics for the commercialization of DetermaRX test.And above all:-The communication by the CMS contractor Palmetto of the definitive medical coverage of DetermaRX, which will begin as the effective date of June 14.This last milestone is, in
Show less
Read more
Impact Snapshot
Event Time:
BIOC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIOC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIOC alerts
High impacting Biocept, Inc. news events
Weekly update
A roundup of the hottest topics